Where Fate Therapeutics Stands With Analysts

Latest Ratings for FATE

Mar 2022HC Wainwright & Co.MaintainsBuy
Dec 2021Morgan StanleyMaintainsEqual-Weight
Dec 2021WedbushUpgradesNeutralOutperform

View More Analyst Ratings for FATE

View the Latest Analyst Ratings

Read the full story on Benzinga.com

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.